Latest Dilution News

Talga Group reported record anode production at its EVA plant and significant progress on its 5,000tpa Vittangi anode plant FEED study, alongside strategic partnerships and exploration breakthroughs.

Syntara Limited has raised A$10 million through a two-tranche placement and share purchase plan, backing its Phase 2b myelofibrosis trial and multiple clinical readouts following positive FDA feedback.

Anax Metals’ updated DFS for Whim Creek reveals a 113% surge in free cash flow to A$723 million, underpinned by a decade-long mine life and rapid payback. The company’s $10 million capital raise strengthens its balance sheet following full repayment of a $3.5 million loan.

Neometals Ltd has launched a 1-for-6 entitlement offer at A$0.04 per share alongside a two-tranche placement, targeting a combined A$13 million to advance gold and critical minerals projects.

Actinogen Medical’s pivotal XanaMIA trial clears a key interim hurdle with the Data Monitoring Committee endorsing continuation, while a $16.8 million capital raise and non-dilutive funding bolster its balance sheet ahead of final results due November 2026.

Thor Energy secured A$6.56 million from the Molyhil sale, expanded its natural hydrogen portfolio with new Otway Basin licences, and advanced its HY-Range Project geochemistry survey during Q1 2026.

Alicanto Minerals has kicked off a 50,000-metre drilling campaign to expand the 915,000oz Mt Henry gold resource, backed by a fresh $18.1 million non-dilutive funding package and key leadership changes.

Brightstar Resources (ASX:BTR) has fully funded its Goldfields Project development with a $193 million equity raise and a US$120 million senior secured bond, targeting 75,000oz gold production from mid-2027 while progressing Sandstone towards a Final Investment Decision.

Argenica Therapeutics is progressing its ARG-007 drug toward a targeted Phase 2b trial for acute ischaemic stroke, leveraging AI for patient selection and securing key regulatory approvals, while maintaining a solid cash position of $8 million.

Lefroy Exploration has transitioned to producer status with first gold from Lucky Strike, strong drilling results pointing to resource expansion, and a bolstered cash position supported by BML Ventures financing.

Litchfield Minerals secured US$500,000 from BHP's Xplor program and delivered thick copper-zinc intercepts at Oonagalabi, expanding its mineral system model despite operational challenges.

Nexsen Limited has cleared a major FDA regulatory hurdle for its StrepSure rapid Group B Streptococcus test, confirmed a clear 510(k) submission pathway, and secured over A$1.7 million in non-dilutive grants to expand clinical validation and market rollout in Asia-Pacific and neonatal diagnostics.